129 related articles for article (PubMed ID: 13686461)
1. Comparison of properdin titers in sera of normal subjects and patients with leukemia and lymphoma by zymosan and bacteriophage assavs.
BALTCH AL; HASSIRDJIAN A; OSBORNE W; BUNN PA
J Lab Clin Med; 1961 Mar; 57():420-7. PubMed ID: 13686461
[No Abstract] [Full Text] [Related]
2. Comparison between properdin titers obtained in the zymosan assay and in the bacteriophage-neutralization assay. 1. investigation on normal human sera.
LAURELL AB; REYN A
Acta Pathol Microbiol Scand; 1959; 47():405-18. PubMed ID: 14414558
[No Abstract] [Full Text] [Related]
3. The properdin system and immunity. XI. Studies on the interaction of zymosan with the properdin system.
BLUM L; PILLEMER L; LEPOW IH
Z Immun exp ther; 1959; 118():313-28. PubMed ID: 13801695
[No Abstract] [Full Text] [Related]
4. [On the possibility of determination of blood properdin by means of zymosan in the serums of different animal species].
MAZZEI D; TASCHINI P
Policlinico Med; 1959; 66():391-401. PubMed ID: 13853881
[No Abstract] [Full Text] [Related]
5. Comparison between properdin titers obtained in the zymosan assay and in the bacterio-phage-neutralization assay. 2. Investigation on pathological sera.
LAURELL AB; REYN A
Acta Pathol Microbiol Scand; 1959; 47():419-28. PubMed ID: 14414557
[No Abstract] [Full Text] [Related]
6. Studies on the mechanism of properdin--zymosan reaction. The role of polysaccharide structure in combination with properdin.
CSEH G; SZABO I
Acta Microbiol Acad Sci Hung; 1961; 8():181-7. PubMed ID: 13718704
[No Abstract] [Full Text] [Related]
7. [On the problem of the method of determination of properdin in human serum by the zymosan method].
MASHKOV AV; MIKHAILOVA ZM
Zh Mikrobiol Epidemiol Immunobiol; 1962 May; 33():103-8. PubMed ID: 14470783
[No Abstract] [Full Text] [Related]
8. [The usefulness of various zymosan preparations in determination of properdin].
von GRAEVENITZ ; HUSMANN KH; HOEBBEL K
Med Exp Int J Exp Med; 1960; 3():230-6. PubMed ID: 13707673
[No Abstract] [Full Text] [Related]
9. Serum complement and bacteriophage neutralization titers in human infections, leukemias, and lymphomas.
BALTCH AL; OSBORNE W; BUNN PA; CANARILE L; HASSIRDJIAN A
J Lab Clin Med; 1960 Oct; 56():594-606. PubMed ID: 13686462
[No Abstract] [Full Text] [Related]
10. Investigation of the serum properdin levels in neoplastic diseases determined by the bacteriophage neutralization assay.
SEKIGUCHI M; ASHIKAWA K; MOTOYA K; ISHIBASHI Y
Gan; 1962 Jun; 53():129-43. PubMed ID: 13910377
[No Abstract] [Full Text] [Related]
11. Alterations in serum lysozyme and properdin titers of mice following x-irradiation or treatment with zymosan or endotoxin.
HOOK WA; CAREY WF; MUSCHEL LH
J Immunol; 1960 Jun; 84():569-75. PubMed ID: 14402997
[No Abstract] [Full Text] [Related]
12. A factor in rheumatoid arthritic sera interfering in the zymosan assay of properdin.
LAURELL AB
Acta Pathol Microbiol Scand; 1959; 45(4):392-400. PubMed ID: 13660839
[No Abstract] [Full Text] [Related]
13. [Interrelations of zymosan, properdin & tumors. III. Behavior of the properdin level in benzopyrene sarcoma-bearing rats treated with zymosan].
FUMAROLA D; MODICA F
Tumori; 1959; 45(1):46-53. PubMed ID: 13659609
[No Abstract] [Full Text] [Related]
14. Adaptation of the zymosan assay of properdin to animal sera.
KENT JF; TOUSSAINT AJ; HOOK WA
Proc Soc Exp Biol Med; 1957 Dec; 96(3):676-8. PubMed ID: 13505826
[No Abstract] [Full Text] [Related]
15. EVIDENCE FOR IMMUNOLOGICAL SPECIFICITY OF THE PROPERDIN SYSTEM; DEMONSTRATION, ISOLATION AND PROPERTIES OF A SERUM FACTOR WHICH INTERACTS WITH ZYMOSAN AND OTHER POLYSACCHARIDES AT 0 DEGREES CENTIGRADE.
BLUM L
J Immunol; 1964 Jan; 92():61-72. PubMed ID: 14139548
[No Abstract] [Full Text] [Related]
16. [Influencing of the serum properdin levels of patients with neoplasms by parenteral administration of zymosan].
SZABO IK
Orv Hetil; 1960 Feb; 101():222-5. PubMed ID: 13836258
[No Abstract] [Full Text] [Related]
17. Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides.
LANDY M; PILLEMER L
J Exp Med; 1956 Jun; 103(6):823-33. PubMed ID: 13319594
[TBL] [Abstract][Full Text] [Related]
18. [The properdin system and its role in infection and immunity. I. The production of active preparations of zymosan].
NIKITINA VD; KHOLCHEV NV; ANDREEVA ZM; SOKHINA AM; CHERNOKHVOSTOVA EV; PLETENEVA IL
Zh Mikrobiol Epidemiol Immunobiol; 1960 Aug; 31():12-9. PubMed ID: 13729079
[No Abstract] [Full Text] [Related]
19. [Bactericidal activity of normal and low-properdin sera and of properdin-zymosan complexes].
SZEMERE G
Kiserl Orvostud; 1963 Feb; 15():58-61. PubMed ID: 13979914
[No Abstract] [Full Text] [Related]
20. [Influence of subcutaneously and intramuscularly administered zymosan on the properdin titer of serum and on leukocyte count in animal experiments].
ZSEBOK Z; WACHTL I; SZY S; SELLEI G
Orv Hetil; 1960 Feb; 101():226-9. PubMed ID: 13847797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
